Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124392136 | 12439213 | 6 | F | 20160726 | 20160606 | 20160801 | PER | US-PFIZER INC-2016276259 | PFIZER | 51.00 | YR | F | Y | 103.00000 | KG | 20160801 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124392136 | 12439213 | 1 | PS | DILANTIN | PHENYTOIN | 1 | Oral | UNK | 10151 | ||||||||||
| 124392136 | 12439213 | 2 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, 2X/DAY | 10151 | 100 | MG | BID | |||||||
| 124392136 | 12439213 | 3 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, 3X/DAY | 10151 | 100 | MG | TID | |||||||
| 124392136 | 12439213 | 4 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | 2X/DAY; 50 MG/500 MG, TWICE A DAY | 0 | BID | ||||||||||
| 124392136 | 12439213 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 90 MG, DAILY; TAKING A TABLET OF 30 MG AND 60 MG EACH, ONCE DAILY | 0 | 90 | MG | TABLET | ||||||||
| 124392136 | 12439213 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 1X/DAY; 75 | 0 | QD | ||||||||||
| 124392136 | 12439213 | 7 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0.625 MG, 1X/DAY | 0 | .625 | MG | QD | ||||||||
| 124392136 | 12439213 | 8 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | AS NEEDED; TAKING IT AS NEEDED OR LIKE TWICE A DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124392136 | 12439213 | 1 | Seizure |
| 124392136 | 12439213 | 4 | Diabetes mellitus |
| 124392136 | 12439213 | 5 | Depression |
| 124392136 | 12439213 | 6 | Thyroid disorder |
| 124392136 | 12439213 | 7 | Hormone level abnormal |
| 124392136 | 12439213 | 8 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124392136 | 12439213 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124392136 | 12439213 | Condition aggravated | |
| 124392136 | 12439213 | Dizziness | |
| 124392136 | 12439213 | Fall | |
| 124392136 | 12439213 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124392136 | 12439213 | 1 | 2014 | 0 |